6:11 PM
 | 
Sep 25, 2013
 |  BC Extra  |  Financial News

Evoke raises $25.2 million in IPO

Gastrointestinal disease company Evoke Pharma Inc. (NASDAQ:EVOK) raised $25.2 million through the sale of 2.1 million shares at $12 in an IPO at the low end...

Read the full 113 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >